Dementia News and Research

Latest Dementia News and Research

Modifications to Phase II study AD201 and open label extension study AD251 for ELND005 notified

Elan Corporation, plc and Transition Therapeutics, Inc. today notified clinical investigators of modifications to the Phase II study AD201 and open label extension study AD251 for ELND005, a compound being developed for the potential treatment of Alzheimer’s disease.

15 Dec 2009

Brain plaques associated with increased risk of Alzheimer's disease

Scientists have long assumed that amyloid brain plaques found in autopsies of Alzheimer's patients are harmful and cause Alzheimer's disease. But autopsies of people with no signs of mental impairment have also revealed brain plaques, challenging this theory.

15 Dec 2009

ZYPREXA RELPREVV approved by FDA

The U.S. Food and Drug Administration (FDA) approved ZYPREXA RELPREVV (olanzapine) For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company announced today.

14 Dec 2009

At the Crossroads: A guide to Alzheimer’s disease, dementia and driving

Every 70 seconds, someone develops Alzheimer’s disease.¹ In conjunction with National Older Driver Safety Awareness Week, Dec. 6-12, leading researchers are joining forces to encourage families to talk openly with loved ones about driving as soon as they are diagnosed with a form of dementia.

14 Dec 2009

Uppsala University Hospital orders CELDA from Likvor for diagnosing NPH

LinkMed’s portfolio company Likvor has received an order for Likvor CELDA™ from Uppsala University Hospital (Akademiska Universitetssjukhuset).

11 Dec 2009

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Treatment with once-monthly INVEGA® SUSTENNA(TM) is not inferior to treatment with bi-weekly RISPERDAL® CONSTA®, according to new data from a comparative study of both treatments in patients with schizophrenia. Results of the 13-week clinical trial were released this week.

10 Dec 2009

Cell transplants may yield new therapies for dementia patients

Nerve cells transplanted into brain-damaged rats helped them to fully recover their ability to learn and remember, probably by promoting nurturing, protective growth factors, according to a new study.

10 Dec 2009

Studies raise questions about the role and responsibilities of patients on medication safety

In a new study to asses patient awareness of medications prescribed during a hospital visit, 44% of patients believed they were receiving a medication they were not, and 96% were unable to recall the name of at least one medication that they had been prescribed during hospitalization. These findings are published today in the Journal of Hospital Medicine.

10 Dec 2009

National Institute on Aging awards grant to study age-related brain disorders

Dr. Rong Zhang, a researcher at the Institute for Exercise and Environmental Medicine at Texas Health Presbyterian Hospital Dallas, has been awarded a four-year grant from the National Institute on Aging to research the connection between exercise and brain function as people age.

9 Dec 2009

Vitamins and nutriceuticals improve memory and cognitive performance, shows study

A recent study presented at the Gerontological Society of America's 62nd Annual Scientific Meeting shows that a combination of vitamins and nutriceuticals improves memory and cognitive performance in community-dwelling adults.

8 Dec 2009

New research discovers link between HIV-related cognitive deficits and Alzheimer's-related dementia

More than half of HIV patients experience memory problems and other cognitive impairments as they age, and doctors know little about the underlying causes. New research from Washington University School of Medicine in St. Louis suggests HIV-related cognitive deficits share a common link with Alzheimer's-related dementia: low levels of the protein amyloid beta in the spinal fluid.

8 Dec 2009

Study suggests sustained health risks linked to adverse childhood experiences

Research from the Institute of Psychiatry at King's College London has found that negative experiences in childhood may alter not only mental health but also physical health, into middle age and beyond.

8 Dec 2009

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years old.

4 Dec 2009

FDA approves once-daily SEROQUEL XR Extended Release Tablets

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as adjunctive (add-on) treatment to antidepressants in adults with Major Depressive Disorder (MDD).

4 Dec 2009

Long term care insurance and the home care option make it easier for Austin couple

After 40 years of exploring the world together, John Austin and his wife, Betty, now have different adventures. Diagnosed with Alzheimer's five years ago, "Betty has become my whole world," Mr. Austin says.

4 Dec 2009

New tool may allow doctors to predict long-term survival rates of dialysis patients

A new model can help physicians determine if a kidney disease patient on dialysis is likely to die within the next few months, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

4 Dec 2009

TapeBeat.Com posts research on GeneLink

TapeBeat.Com the news and community portal for the serious investor has posted research on GeneLink (GNLK). GeneLink’s approach to well-being utilizes the science of pharmacogenenomics - using individual genetic variations to customize nutritional, skincare products and health maintenance products.

4 Dec 2009

New biochemical probe may help in identifying toxic proteins associated with Alzheimer's disease

Alzheimer's disease (AD) is one of the most heartbreaking diagnoses a person can receive. This irreversible, progressive brain disease slowly destroys memory and thinking skills and eventually even the ability to carry out the simplest tasks

4 Dec 2009

Videos can help overcome communication barriers and influence patients' choices for medical care

Patients with terminal brain cancer who watched a brief video illustrating options for end-of-life care were significantly more likely to indicate a preference for comfort measures only than were patients who listened to a verbal description of treatment choices.

3 Dec 2009

Lung disease linked to the use of contaminated well water in a CPAP machine

Many people rely on continuous positive airway pressure (CPAP) machines as a safe and effective treatment for sleep apnea. But a new case report describes a rare complication—a lingering inflammatory disease of the lungs, apparently related to the use of contaminated well water in a CPAP machine. The report appears in the December Southern Medical Journal, official journal of the Southern Medical Association.

3 Dec 2009

Dementia News and Research

Latest Dementia News and Research

Modifications to Phase II study AD201 and open label extension study AD251 for ELND005 notified

Brain plaques associated with increased risk of Alzheimer's disease

ZYPREXA RELPREVV approved by FDA

At the Crossroads: A guide to Alzheimer’s disease, dementia and driving

Uppsala University Hospital orders CELDA from Likvor for diagnosing NPH

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Cell transplants may yield new therapies for dementia patients

Studies raise questions about the role and responsibilities of patients on medication safety

National Institute on Aging awards grant to study age-related brain disorders

Vitamins and nutriceuticals improve memory and cognitive performance, shows study

New research discovers link between HIV-related cognitive deficits and Alzheimer's-related dementia

Study suggests sustained health risks linked to adverse childhood experiences

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

FDA approves once-daily SEROQUEL XR Extended Release Tablets

Long term care insurance and the home care option make it easier for Austin couple

New tool may allow doctors to predict long-term survival rates of dialysis patients

TapeBeat.Com posts research on GeneLink

New biochemical probe may help in identifying toxic proteins associated with Alzheimer's disease

Videos can help overcome communication barriers and influence patients' choices for medical care

Lung disease linked to the use of contaminated well water in a CPAP machine

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Dementia News and Research

Latest Dementia News and Research

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in